2023
DOI: 10.1101/2023.03.02.23286705
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

AI chatbots not yet ready for clinical use

Abstract: As large language models (LLMs) expand and become more advanced, so does the natural language processing capabilities of conversational AI, or ‘chatbots’. OpenAI’s recent release, ChatGPT, uses transformer-based model and deep learning algorithms to enable human-like text generation and question-answering on general domain knowledge, while a healthcare-specific Large Language Model (LLM), Gatortron has focused on the real-world healthcare domain knowledge. As LLMs advance to achieve near human-level performanc… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 23 publications
0
8
0
Order By: Relevance
“…Given their rapid rate of advancement, it is probable that language model-based conversational AI will soon be developed for healthcare use. 34 In the near future, the identified shortcomings from our study could be overcome, and AI-based clinical decision support tools could prove valuable in decreasing HCP burnout and enhancing the quality of care. More research involving the use of chatbots in different aspects of patients' drug therapy is needed and collecting such data can decipher chatbot potentials and limitations and consequently help in further development of AI models for therapy optimization.…”
Section: Discussionmentioning
confidence: 92%
See 2 more Smart Citations
“…Given their rapid rate of advancement, it is probable that language model-based conversational AI will soon be developed for healthcare use. 34 In the near future, the identified shortcomings from our study could be overcome, and AI-based clinical decision support tools could prove valuable in decreasing HCP burnout and enhancing the quality of care. More research involving the use of chatbots in different aspects of patients' drug therapy is needed and collecting such data can decipher chatbot potentials and limitations and consequently help in further development of AI models for therapy optimization.…”
Section: Discussionmentioning
confidence: 92%
“…Overall, our analysis revealed chatbots to be a promising tool for HCP. Given their rapid rate of advancement, it is probable that language model‐based conversational AI will soon be developed for healthcare use 34 . In the near future, the identified shortcomings from our study could be overcome, and AI‐based clinical decision support tools could prove valuable in decreasing HCP burnout and enhancing the quality of care.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…Another signi cant area for investigation is the incorporation of social determinants of health (SDOH) and real, anonymized, consented patient cases to add complexity to LLM assessments [20,30,40]. While there is an abundance of research utilizing USMLE standardized, textbook-style questions, there is a scarcity of studies that leverage real patient data, which has been recognized as a limitation in several papers [20,30,40]. By including social factors such as socioeconomic status (SES), race, and sexuality, biases in the answers generated by LLMs can be directly assessed.…”
Section: Discussionmentioning
confidence: 99%
“…These AI models have the ability to engage in nuanced and complex conversations 10–12 , making them ideal candidates for extracting comprehensive patient histories and assisting physicians in generating differential diagnoses. However, a considerable gap remains in assessing these models’ readiness for application in real-world clinical scenarios 1315 .…”
Section: Introductionmentioning
confidence: 99%